🔎 Trials Near Me

ホーム › ウイルス感染症 › オハイオ

オハイオにおけるウイルス感染症の臨床試験

オハイオ内の拠点で、ウイルス感染症に関する9件の研究が参加者を募集しています。

オハイオ内の都市

公式研究テキスト(英語)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Columbus
  • Research Site, Toledo
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05624450

A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

  • University Hospitals Cleveland Medical Center, Cleveland
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07214571

A Study of COVID-19 Vaccine(s) in Children and Adults

  • Dayton Clinical Research, Dayton
  • Senders Pediatrics, South Euclid
被験者募集中第3相健康なボランティア歓迎
5歳以上 · 全性別 · 2026/09/28更新 · NCT07798648

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Remington-Davis, Inc, Columbus
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • University of Cincinnati Medical Center, Cincinnati
  • University of Cincinnati College of Medicine (UC Holmes), Cincinnati
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07013474

Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant

  • Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中第2相
全年齢 · 全性別 · 2026/09/04更新 · NCT04230356

Donor-Derived Viral Specific T-cells (VSTs)

  • Akron Children's Hospital, Akron
  • Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中第1/2相
4 Weeks · 全性別 · 2026/09/04更新 · NCT02048332

Third Party Viral Specific T-cells (VSTs)

  • Akron Children's Hospital, Akron
  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • The Ohio State University Wexner Medical Center - James Cancer Hospital, Columbus
被験者募集中第2相
2 Days · 全性別 · 2026/09/04更新 · NCT02532452

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

  • Nationwide Children's Hosptial, Columbus
被験者募集中第1/2相
1 Month – 79 Years · 全性別 · 2026/04/15更新 · NCT04197596

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。